Which Markets Demand Lab Testing Before You Can Sell

Budgeting for international expansion gets thrown off constantly by one wrong assumption: that the compliance workload looks roughly the same everywhere. It doesn't, and the biggest variable isn't paperwork volume, it's whether a market requires actual laboratory testing of your finished product before you're allowed to sell it at all.

The notification model: paperwork, not a lab bench

Canada runs a notification model. You file a Cosmetic Notification Form through the Cosmetic Notification System, listing every ingredient by INCI name with concentration or a concentration range, and you check the formula against the Cosmetic Ingredient Hotlist for prohibited or restricted substances. This is a notification, not a pre-market approval, so there's no government lab testing your product before it can be sold. The 10-day filing window after first sale reflects that lighter posture: you're not waiting on results, you're documenting a formula you're already confident is safe based on your own safety substantiation.

This doesn't mean no testing ever happens. Responsible brands still run their own stability testing, microbial challenge testing, and sometimes third-party safety assessments to back up the safety claims they're making. It just means that testing isn't a mandatory regulatory gate before you're legally allowed to sell in Canada.

The EU: a documented safety file, assessed by a professional

The EU sits in between. Under Regulation (EC) No 1223/2009, you need a Cosmetic Product Safety Report signed by a qualified safety assessor, kept inside a Product Information File, before your Responsible Person notifies the product through CPNP. That safety assessor is reviewing your formula, your ingredient safety data, and often existing toxicological data on each ingredient, but this isn't the same as a government-mandated finished-product lab test in every case. It's closer to a rigorous documented safety review than a testing gate, though the safety assessor may require specific testing data to complete their assessment depending on the ingredients involved.

China: the test-heavy end of the spectrum

China's system is meaningfully heavier. Many cosmetic categories, particularly what China classifies as "special use" cosmetics and certain new ingredients, require actual registration involving laboratory testing before the product can be sold, alongside working through a domestic responsible agent. This is a genuinely different order of magnitude in both time and cost compared to Canada's notification model, and it's the market where brands most often underestimate the runway needed, because they're mentally pricing it against a Canadian or US timeline.

The US: substantiation, not a testing mandate

Under MoCRA, US cosmetics need facility registration and product listing with the FDA, a named responsible person, and safety substantiation, along with adverse event recordkeeping. Safety substantiation is a real obligation, but it's not the same as a mandatory pre-market lab testing regime the way China's special-use category can be. Some small businesses are exempt from the registration and listing pieces entirely, which is worth checking against current FDA guidance since exemption criteria are the kind of detail that can shift.

A rough spectrum, lightest to heaviest

Market	Testing posture
Canada	Notification-based, no mandatory pre-market lab testing gate
US	Safety substantiation required, no blanket lab-testing mandate
EU	Documented safety assessment by a qualified professional, PIF/CPSR
Australia	Ingredients assessed via AICIS inventory/introduction categories
China	Registration with mandatory lab testing for many categories

Why this should shape your rollout order

If cash and timeline are tight, entering through a lighter-touch market first, building sales history, safety documentation, and formula stability data, makes the heavier markets easier later. Data you generate for one market's safety file often has some reuse value elsewhere, even when the formal requirements differ.

Cosmetic Comply currently handles the Canadian notification process end to end, matching ingredients to INCI and CAS, screening against the Hotlist, and filing once a reviewer signs off, with the US, EU, and Australia on the roadmap. If China's testing-heavy path is part of your long-term plan, it's worth treating it as its own project with its own budget line rather than an extension of whatever you did for Canada.